HomeVTRLY • OTCMKTS
add
Vitrolife ADR
In the news
Financials
Income Statement
Revenue
Net income
| (SEK) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 842.00M | 0.12% |
Operating expense | 333.00M | 6.39% |
Net income | 100.00M | -13.04% |
Net profit margin | 11.88 | -13.09% |
Earnings per share | 0.74 | -12.94% |
EBITDA | 257.00M | -5.51% |
Effective tax rate | 29.29% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.05B | 11.30% |
Total assets | 16.63B | -1.43% |
Total liabilities | 3.50B | -3.71% |
Total equity | 13.13B | — |
Shares outstanding | 135.42M | — |
Price to book | 0.18 | — |
Return on assets | 2.20% | — |
Return on capital | 2.43% | — |
Cash Flow
Net change in cash
| (SEK) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 100.00M | -13.04% |
Cash from operations | 69.00M | -65.15% |
Cash from investing | -49.00M | -28.95% |
Cash from financing | -36.00M | 64.00% |
Net change in cash | -81.00M | -194.19% |
Free cash flow | 57.12M | -58.00% |
About
Founded
1989
Website
Employees
1,150
